Search hospitals > Pennsylvania > Lewisburg

Geisinger Medical Oncology-Lewisburg

Claim this profile
Lewisburg, Pennsylvania 17837
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lymphoma
260 reported clinical trials
19 medical researchers
Photo of Geisinger Medical Oncology-Lewisburg in LewisburgPhoto of Geisinger Medical Oncology-Lewisburg in LewisburgPhoto of Geisinger Medical Oncology-Lewisburg in Lewisburg

Summary

Geisinger Medical Oncology-Lewisburg is a medical facility located in Lewisburg, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma and other specialties. Geisinger Medical Oncology-Lewisburg is involved with conducting 260 clinical trials across 322 conditions. There are 19 research doctors associated with this hospital, such as Raghava Reddy Levaka Veera, Joseph J. Vadakara, Sorab Gupta, and Anand Mahadevan.

Area of expertise

1Cancer
Global Leader
Geisinger Medical Oncology-Lewisburg has run 73 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Geisinger Medical Oncology-Lewisburg has run 47 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
ER positive
HER2 negative

Top PIs

Clinical Trials running at Geisinger Medical Oncology-Lewisburg

Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Colorectal Cancer
Small Cell Lung Cancer
Melanoma
Cutaneous Melanoma
Anal Cancer
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Image of trial facility.

Whole Brain Radiotherapy + Stereotactic Radiosurgery

for Brain Metastasis

This study is evaluating whether a combination of radiation therapy and memantine may be effective in treating cancer that has come back in the brain. original:
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Geisinger Medical Oncology-Lewisburg?
Geisinger Medical Oncology-Lewisburg is a medical facility located in Lewisburg, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma and other specialties. Geisinger Medical Oncology-Lewisburg is involved with conducting 260 clinical trials across 322 conditions. There are 19 research doctors associated with this hospital, such as Raghava Reddy Levaka Veera, Joseph J. Vadakara, Sorab Gupta, and Anand Mahadevan.